An overview of targeted alpha therapy with 225Actinium and 213Bismuth A Morgenstern, C Apostolidis, C Kratochwil, M Sathekge, L Krolicki, ... Current radiopharmaceuticals 11 (3), 200-208, 2018 | 326 | 2018 |
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study M Sathekge, F Bruchertseifer, O Knoesen, F Reyneke, I Lawal, T Lengana, ... European journal of nuclear medicine and molecular imaging 46, 129-138, 2019 | 320 | 2019 |
Antimicrobial peptides: Their role as infection‐selective tracers for molecular imaging T Ebenhan, O Gheysens, HG Kruger, JR Zeevaart, MM Sathekge BioMed research international 2014 (1), 867381, 2014 | 246 | 2014 |
Intraindividual comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the prospective evaluation of patients with newly diagnosed prostate carcinoma: a pilot study FL Giesel, L Will, I Lawal, T Lengana, C Kratochwil, M Vorster, O Neels, ... Journal of Nuclear Medicine 59 (7), 1076-1080, 2018 | 184 | 2018 |
Predictors of overall and disease-free survival in metastatic castration-resistant prostate cancer patients receiving 225Ac-PSMA-617 radioligand therapy M Sathekge, F Bruchertseifer, M Vorster, IO Lawal, O Knoesen, ... Journal of Nuclear Medicine 61 (1), 62-69, 2020 | 169 | 2020 |
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours C Van de Wiele, V Kruse, P Smeets, M Sathekge, A Maes European journal of nuclear medicine and molecular imaging 40, 290-301, 2013 | 169 | 2013 |
Dual time-point FDG PET/CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area MM Sathekge, A Maes, H Pottel, A Stoltz, C Van De Wiele South African medical journal 100 (9), 598-561, 2010 | 163 | 2010 |
Extraordinary arousal from semi-comatose state on zolpidem RP Clauss, WM Güldenpfennig, HW Nel, MM Sathekge, ... South African Medical Journal 90 (1), 68-72, 2000 | 145 | 2000 |
213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer M Sathekge, O Knoesen, M Meckel, M Modiselle, M Vorster, S Marx European Journal of Nuclear Medicine and Molecular Imaging 44, 1099-1100, 2017 | 143 | 2017 |
Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients FL Giesel, C Kratochwil, J Schlittenhardt, K Dendl, M Eiber, F Staudinger, ... European journal of nuclear medicine and molecular imaging 48 (13), 4377-4385, 2021 | 139 | 2021 |
Advances in imaging of tuberculosis: the role of: 18: F-FDG PET and PET/CT M Vorster, MM Sathekge, J Bomanji Current opinion in pulmonary medicine 20 (3), 287-293, 2014 | 133 | 2014 |
PET/CT imaging of Mycobacterium tuberculosis infection AO Ankrah, TS van der Werf, EFJ de Vries, RAJO Dierckx, MM Sathekge, ... Clinical and Translational Imaging 4, 131-144, 2016 | 131 | 2016 |
FDG-PET imaging in HIV infection and tuberculosis M Sathekge, A Maes, C Van de Wiele Seminars in nuclear medicine 43 (5), 349-366, 2013 | 121 | 2013 |
68Ga-FAPI-PET/CT in patients with various gynecological malignancies K Dendl, SA Koerber, R Finck, KMG Mokoala, F Staudinger, L Schillings, ... European journal of nuclear medicine and molecular imaging 48 (12), 4089-4100, 2021 | 119 | 2021 |
68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients M Sathekge, T Lengana, M Modiselle, M Vorster, JR Zeevaart, A Maes, ... European journal of nuclear medicine and molecular imaging 44, 689-694, 2017 | 117 | 2017 |
68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli? T Lengana, IO Lawal, TG Boshomane, GO Popoola, KMG Mokoala, ... Clinical genitourinary cancer 16 (5), 392-401, 2018 | 115 | 2018 |
Evaluation of thyroid nodules with technetium‐99m MIBI and technetium‐99m pertechnetate MM Sathekge, RB Mageza, MN Muthuphei, MCM Modiba, RC Clauss Head & neck 23 (4), 305-310, 2001 | 112 | 2001 |
Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis M Sathekge, A Maes, M Kgomo, A Stoltz, C Van de Wiele Journal of Nuclear Medicine 52 (6), 880-885, 2011 | 109 | 2011 |
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH … H Ahmadzadehfar, K Rahbar, RP Baum, R Seifert, K Kessel, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 113-122, 2021 | 100 | 2021 |
Prostate cancer: epigenetic alterations, risk factors, and therapy MM Kgatle, AA Kalla, MM Islam, M Sathekge, R Moorad Prostate cancer 2016 (1), 5653862, 2016 | 98 | 2016 |